Companies › NPCE

NEUROPACE INC (NPCE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001528287 · EDGAR filings · Updated 2026-07-28

NEUROPACE INC (NPCE) has reported institutional ownership of 78.6%, with 112 institutional managers holding positions valued at $347.9M per the latest 13F reporting period.

Filings this week (1)

• 2026-07-28 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-25 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-08 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEUROPACE INC has 112 institutional holders and institutional ownership of 78.6%.

Insider activity

Insiders reported 75 transactions (0 buys, 3 sells) across 9 reporting insiders, with a net reported value of −$3.06M.

Related companies

SUTRO BIOPHARMA INC (STRO) · FORTE BIOSCIENCES INC (FBRX) · ATAIBECKLEY (ATAI) · ROCKET PHARMACEUTICALS I (RCKT) · BENITEC BIOPHARMA INC (BNTC) · NEUROGENE INC (NGNE)